Allergan Aesthetics Highlights Shifting Trends in Modern Aesthetic Care Through Global Survey and Enhanced Educational Initiatives
Allergan Aesthetics, a division of AbbVie and a globally recognized leader in the field of medical aesthetics, has unveiled a comprehensive new body of global consumer research that sheds light on how patient expectations in aesthetic medicine are rapidly evolving. The company also announced that it will introduce the next phase of its proprietary AA Signature™ framework during the prestigious Aesthetic & Anti-Aging Medicine World Congress 2026 in Monaco. This development marks a significant step forward in redefining how aesthetic treatments are approached, emphasizing personalization, multimodal strategies, and long-term patient satisfaction.
A Transformational Shift in Patient Expectations
Medical aesthetics is undergoing a profound transformation. No longer limited to isolated procedures or quick cosmetic fixes, patients are increasingly adopting a broader and more holistic view of their aesthetic journeys. This shift is driven by a growing awareness of available treatments, advancements in technology, and a desire for natural-looking, sustainable results.
Mark Wilson, Senior Vice President, International at Allergan Aesthetics, highlighted this transition, emphasizing that today’s patients are more informed, engaged, and intentional in their treatment decisions. According to Wilson, patients are not only open to combining multiple procedures but are actively seeking structured, personalized plans that evolve over time. These plans aim to enhance natural beauty rather than drastically alter appearance, reflecting a preference for authenticity and subtlety.
The company’s latest research reinforces what many practitioners are already observing in clinical practice: patients want clarity, guidance, and a collaborative approach with their healthcare providers. This evolution underscores the need for frameworks that can support complex decision-making while maintaining patient-centric outcomes.
Insights from One of the Largest Global Consumer Studies
The newly released findings are based on one of the most extensive global studies ever conducted in the aesthetics sector. Surveying more than 12,000 beauty-engaged consumers across nine countries, the research provides a detailed understanding of patient attitudes, motivations, and expectations.
The results reveal a strong inclination toward multimodal treatment strategies:
- 62% of respondents expressed interest in combining multiple aesthetic treatments.
- 59% indicated they are likely to adopt a structured, multi-treatment approach.
- 78% stated they would feel more satisfied working with a practitioner on a long-term, agreed-upon treatment plan.
These findings highlight a critical shift from reactive, one-time procedures to proactive, ongoing aesthetic care. Patients increasingly view aesthetic treatments as part of a continuous journey rather than isolated interventions.
To encapsulate these insights, Allergan Aesthetics will officially launch a new report titled “Layered Beauty: The New Aesthetic Mindset” at AMWC 2026. The report explores how layered, integrated approaches to treatment can deliver more natural, harmonious results while improving patient satisfaction.
The Evolution of AA Signature™: One Year Later
Originally developed in collaboration with leading global experts, AA Signature™ is a portfolio-driven framework designed to support personalized, multimodal treatment planning. It integrates Allergan Aesthetics’ diverse product offerings into cohesive treatment strategies tailored to individual patient needs.
One year after its introduction, the framework is undergoing a significant evolution. This next phase reflects changing consumer expectations and incorporates:
- New “Signature Looks” designed to achieve refined, natural outcomes
- Expanded treatment indications
- Enhanced integration across products and modalities
The goal is to provide practitioners with a structured yet flexible system that enables them to deliver highly customized treatment plans.
Skin Quality Takes Center Stage
One of the most notable insights from the research is the growing importance of skin quality as a foundational element of aesthetic care. The data shows:
- 74% of respondents plan to improve their facial skin quality within the next year
- 63% identified improving elasticity and addressing signs of aging as top priorities
- Approximately 30% view skin quality improvement as the starting point for a broader treatment plan
These findings indicate that patients are increasingly prioritizing overall skin health rather than focusing solely on isolated concerns such as wrinkles or volume loss. This shift aligns with a more holistic understanding of aging, where multiple factors—including texture, tone, elasticity, and hydration—are addressed simultaneously.
Introducing AA Signature™ Skin360+
In response to these insights, Allergan Aesthetics is introducing AA Signature™ Skin360+, an advanced framework designed to address skin health across multiple layers and dimensions. This approach recognizes that the skin is a complex, dynamic organ that requires comprehensive treatment strategies.
AA Signature™ Skin360+ integrates:
- Injectable treatments
- Energy-based devices
- Sequential treatment planning
By combining these modalities, practitioners can deliver more consistent and effective results. The framework also emphasizes the importance of timing and sequencing, ensuring that treatments are administered in a way that maximizes efficacy while minimizing risk.
At AMWC 2026, Allergan Aesthetics will collaborate with globally recognized experts to provide practical guidance on implementing this approach in clinical practice. This includes step-by-step strategies for integrating different treatment modalities into cohesive patient journeys.
Education and Innovation Through the Allergan Medical Institute
A key component of Allergan Aesthetics’ strategy is education. Through the Allergan Medical Institute (AMI), the company aims to equip healthcare professionals with the knowledge and tools needed to deliver advanced aesthetic treatments.
At AMWC 2026, AMI will host two flagship symposia designed to bring the AA Signature™ framework to life:
Day One: Personalized Multimodal Skin Journeys
This session will focus on the practical application of AA Signature™ Skin360+, showcasing how products such as:
- Juvéderm
- BOTOX
- HArmonyCa
can be combined with energy-based devices to create comprehensive treatment plans.
Renowned experts, including Dr. Reha Yavuzer, Dr. Julia Carroll, Dr. Andre Braz, Dr. Raafat Lakis, and Dr. Sheila Mulatti, will share their clinical insights and real-world experiences.
Day Two: Innovation and the Future of Aesthetics
The second symposium will explore the integration of AA Signature™ with MD Codes, a structured, anatomy-based approach to injectable treatments developed by Mauricio De Maio.
This session will focus on:
- Lower face refinement
- Chin and jawline contouring
- Sequential, anatomy-led treatment planning
Live injection demonstrations will illustrate how subtle, incremental changes can produce meaningful, natural-looking results.
Advancing Science in Neurotoxins and Multimodal Treatments
In addition to its educational symposia, Allergan Aesthetics will host a Global Medical Affairs Symposium titled “Innovation in Neurotoxins and Multimodal Approach: Transforming Aesthetic Practice Through Advanced Science.”
This session will address:
- Unmet needs in the neurotoxin space
- The expanding role of neurotoxins beyond dynamic wrinkle treatment
- The integration of neurotoxins into broader multimodal strategies
Expert panelists, including Dr. Steven Dayan, Dr. Terrane Keaney, Ada Regina Trindade de Almeida, and Sylwia Lipko-Godlewska, will provide insights into the latest scientific advancements and clinical applications.
Showcasing Scientific Leadership
Allergan Aesthetics will further reinforce its leadership in the field by presenting 21 scientific e-posters at AMWC 2026. These presentations will highlight:
- Ongoing innovation across its product portfolio
- Clinical evidence supporting multimodal treatment approaches
- Advances in patient outcomes and safety
This robust scientific presence underscores the company’s commitment to evidence-based practice and continuous improvement.
The Intersection of Aging Science and Aesthetic Medicine
Another key theme at AMWC 2026 will be the convergence of aesthetics and longevity science. During a dedicated session titled “Geroscience, AI & the Future of Aesthetic Longevity,” global experts will explore how advancements in aging research are shaping the future of aesthetic medicine.
Topics will include:
- The biological mechanisms of aging
- The role of artificial intelligence in treatment planning
- The translation of longevity science into clinical practice
This discussion reflects a growing trend toward integrating aesthetic treatments with broader health and wellness strategies, positioning aesthetics as part of a comprehensive approach to aging.
An Immersive Experience at AMWC 2026
Throughout the congress, attendees will have the opportunity to engage directly with Allergan Aesthetics at its dedicated booth. The company will offer:
- Interactive demonstrations of the AA Signature™ framework
- “Meet the Expert” sessions
- Hands-on learning opportunities
This immersive experience is designed to help practitioners translate theory into practice, enhancing their ability to deliver personalized, high-quality care.
Driving the Future of Medical Aesthetics
Allergan Aesthetics’ integrated presence at AMWC 2026 reflects its broader mission: to advance the field of medical aesthetics through innovation, education, and science. By combining cutting-edge research with practical frameworks and comprehensive training, the company aims to empower practitioners and improve patient outcomes worldwide.
The evolution of AA Signature™ and the introduction of Skin360+ represent a forward-looking approach that aligns with the changing needs of modern patients. As the industry continues to evolve, the emphasis on personalization, multimodal strategies, and long-term planning is likely to become the new standard of care.
In this rapidly changing landscape, Allergan Aesthetics is positioning itself at the forefront—helping to shape the future of aesthetic medicine while ensuring that patient needs remain at the center of every innovation.
Source Link:https://news.abbvie.com/
